Episode Description
GLP-1 medications are changing far more than the way obesity is treated. eMarketer Senior Analyst Beth Bulik joins Stewart Gandolf to explore how GLP-1s are influencing consumer behavior, healthcare access, food and fitness habits, employer benefits, and entire industries.



























